Skip to main content

Table 1 Distribution of patient characteristics by group

From: Evaluating the impact of onsite diabetes education teams in primary care on clinical outcomes

Ā 

Control (nā€‰=ā€‰284)

Intervention (nā€‰=ā€‰487)

Standard mean difference

Continuous variables

Mean

SE or Quartiles

Mean

SE or Quartiles

Ā 

Age

61.71

0.80

58.00

0.61

0.275

Years since diagnosisa

9.90

(3.27,13.99)

5.58

(0.83,11.00)

0.256

Categorical variables

n

%

n

%

Ā 

ā€ƒSex

Ā Ā Ā Ā 

0.066

ā€ƒā€ƒMale

151

53.17

275

56.47

Ā 

ā€ƒā€ƒFemale

133

46.83

212

43.53

Ā 

ā€ƒTreatment modality

Ā Ā Ā Ā 

0.238

ā€ƒā€ƒDiet

44

15.55

52

10.68

Ā 

ā€ƒā€ƒOrals

179

63.25

323

66.32

Ā 

ā€ƒā€ƒOrals + Insulin / Insulin only

60

21.20

112

23

Ā 

ā€ƒSmokerb

Ā Ā Ā Ā 

0.104

ā€ƒā€ƒCurrently yes

49

18.15

104

22.41

Ā 

ā€ƒā€ƒCurrently no

221

81.85

360

77.59

Ā 

ā€ƒSite and grouping

Ā Ā Ā Ā 

0.270

ā€ƒā€ƒFamily health team affiliated with a hospital

135

47.54

295

60.57

Ā 

ā€ƒā€ƒFamily health team other

108

38.03

146

29.98

Ā 

ā€ƒā€ƒFamily group practice or solo practice

41

14.43

46

9.45

Ā 

ā€ƒā€ƒAny type of comorbidity (Yes)

268

94.4

438

89.9

0.198

ā€ƒā€ƒSpecific comorbidity condition

Ā Ā Ā Ā Ā 

ā€ƒā€ƒCardiovascular disease (Yes)

81

30.1

98

22.4

0.199

ā€ƒā€ƒHypercholesterolemia (Yes)

49

`8.4

83

18.9

0.088

ā€ƒā€ƒHypertension (Yes)

182

67.7

271

61.9

0.153

ā€ƒā€ƒHyperlipidemia (Yes)

105

39

156

35.6

0.114

ā€ƒā€ƒMH (Yes)

68

25.3

127

29

0.119

ā€ƒā€ƒNephropathy (Yes)

21

7.8

41

9.4

0.102

ā€ƒā€ƒNeuropathy (Yes)

22

8.2

35

8

0.087

ā€ƒā€ƒObesityc (Yes)

114

42.5

238

54.3

0.238

ā€ƒā€ƒRetinopathy (Yes)

17

6.3

31

7.1

0.091

  1. aYears since diagnosis has missing values. It includes only measurements for 187 patients in the control group and 358 patients in the intervention group
  2. bSmoker has missing values. It includes only measurements for 270 patients in the control group and 464 patients in the intervention group
  3. cObesity as a comorbidity has missing values, it includes only measurements for 268 patients in the control group and 438 patients in the intervention group